BIRC5 and cancer: Whereas abnormal DNA methylation in promoter regions of oncogenes as well as in tumour suppressor genes can be observed in most cancers, both hypermethylation and hypomethylation in the promoter sequence of BIRC5 may correlate with survivin overexpression.